MedTrace Logo

Dilapan-S / Dilasoft E-Registry in Induced Abortion

NCT02318212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 439

Last updated 2017-05-19

No results posted yet for this study

Summary

International Observational E-Registry on the use of osmotic dilators DILAPAN-S® / DILASOFT® for cervical priming prior to induced abortion.

Conditions

  • Abortion, Induced

Interventions

DEVICE

Dilapan-S

Synthetic osmotic dilators Dilapan-S or Dilasoft for cervical priming prior to induced abortion

Sponsors & Collaborators

  • Medicem International CR s.r.o.

    lead INDUSTRY

Principal Investigators

  • Patricia Lohr, MD · British Pregnancy Advisory Service, UK

  • Jiri Hanacek, MD · Institute of Care for Mother and Child, Prague, CZ

  • Natalia Kan, Prof., MD · Research Center for Obstetrics, Gynecology and Perinatology, Moscow

  • John Roizin, MD · Allentown Women´s Center, Bethlehem, PA, US

  • Mary Jane Bovo, MD · Choices Women´s Medical Center, New York

  • LeRoy Carhart, MD · Germantown Reproductive Health Service

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-12-31
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02318212 on ClinicalTrials.gov